| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/16/1999 | US5872122 Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation |
| 02/16/1999 | US5872106 Antimessenger oligonucleotide against urokinase receptor |
| 02/16/1999 | US5872105 Antiparallel binding domain |
| 02/16/1999 | US5872101 Methods of treating neurodegenerative disorders using protease inhibitors |
| 02/16/1999 | US5872100 Peptides containing D-2-Alkyl-Tryptophan |
| 02/16/1999 | US5872099 Administering high molecular weight fraction having higher platelet aggregation activity; treatment of hemophilia a and other blood disorders |
| 02/16/1999 | US5872098 Nematode-extracted anticoagulant protein |
| 02/16/1999 | US5872097 Oligopeptides with affinity to opioid receptors |
| 02/16/1999 | US5872096 Modified sialyl Lewisa compounds |
| 02/16/1999 | US5872095 IL-1 receptor antagonists medicaments |
| 02/16/1999 | US5872094 Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface |
| 02/16/1999 | US5872007 CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer |
| 02/16/1999 | US5872001 Lanthionine antibiotic compositions and methods |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871992 Mammalian endonuclease III, and diagnostic and therapeutic uses thereof |
| 02/16/1999 | US5871989 Phenylalanyl tRNA synthetase alpha subunit polynucleotides from streptococcus pneumoniae |
| 02/16/1999 | US5871982 Hybrid vectors and genes |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871971 Polynucleotide sequences and expression vectors or cells |
| 02/16/1999 | US5871970 Calcium-binding protein |
| 02/16/1999 | US5871969 Treating spinal cord injuries and malaria; antitumor and wound healing agents; diagnosing cancer; genetic engineering |
| 02/16/1999 | US5871968 P21WAF1 derivatives and diagnostic methods |
| 02/16/1999 | US5871967 Cloning of a novel G-Protein coupled 7TM receptor |
| 02/16/1999 | US5871965 Guanylate binding proteins |
| 02/16/1999 | US5871964 Human C-type lectin |
| 02/16/1999 | US5871963 Nucleotide sequences |
| 02/16/1999 | US5871961 Nucleic acids encoding CR2 polypeptides, vector and transformed cell thereof, and expression thereof |
| 02/16/1999 | US5871960 Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof |
| 02/16/1999 | US5871956 Recombinant methods for production of serine inhibitors and DNA sequences useful for same |
| 02/16/1999 | US5871937 Complexing; binding gramnegative endotoxin secreted in gastrointestinal infections |
| 02/16/1999 | US5871936 Detection and treatment of breast cancer using monoclonal antibodies produced by hybridoma formed by fusing mouse lymphocytes and myeloma cells; solid tumor shrinkage |
| 02/16/1999 | US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
| 02/16/1999 | US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines |
| 02/16/1999 | US5871931 Methods for detecting mammalian tub protein and RNA |
| 02/16/1999 | US5871930 High affinity immunoglobulin E receptor-like protein |
| 02/16/1999 | US5871925 Determining whether two microsatellite markers are rearranged in tumor tissue; testing for familial colon cancer gene in humans; diagnosis, prognosis, prevention |
| 02/16/1999 | US5871920 Daz: a gene associated with azoospermia |
| 02/16/1999 | US5871919 Method of identifying agents that affect human NHE3 |
| 02/16/1999 | US5871916 Cancer diagnosis by analyzing gene expression of ecdn paucimolecular protein; receptor binding assays |
| 02/16/1999 | US5871913 Forms a complex with a human immunodeficiency virus envelope glycoprotein |
| 02/16/1999 | US5871777 Incorporation of biologically active molecules into bioactive glasses |
| 02/16/1999 | US5871769 Using magnesium gluconate alone or in combination with antioxidants selected from vitamin e, selenium, glutathione, isopropyl glutathionate and n-acetylcysteine; prevention of oxygen free radical and lipid peroxidation production |
| 02/16/1999 | US5871767 Implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete biologically active material dispersed in biocompatible matrix, surrounded by biocompatible external jacket |
| 02/16/1999 | US5871753 A compound comprising two or more multimerized ligands each independently selected from the group consisting of fk506, fk520 and cyclosporin, or macrocyclic derivatives thereof. |
| 02/16/1999 | US5871750 Leukotoxin vaccine compositions and uses thereof |
| 02/16/1999 | US5871748 Administering to the subject a vaccine complex comprising a live vaccine virus and antibodies bound to said live vaccine virus |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871740 Genetic engineering with proteins, antiinflammatory agents and gene expression |
| 02/16/1999 | US5871739 Pharmaceutical composition |
| 02/16/1999 | US5871737 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/16/1999 | US5871734 Treatment for asthma with VLA-4 blocking agents |
| 02/16/1999 | US5871733 Viricides with intracellular adhesion molecule proteins for binding rhinovirus |
| 02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |
| 02/16/1999 | US5871731 Oral administration of immunoglobulin preparations for treatment of chronic pain syndrome |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | US5871728 Enhancing tolerogenicity in host mammal to transplant graft specimen from donor; propagation in cytokine prior to administering |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | US5871725 In the absence of alone or in combination with interleukin-two; anticarcinogenic agents |
| 02/16/1999 | US5871724 Administering to the subject an amount of a transforming growth factor beta 3 effective to slow the growth of normal cells |
| 02/16/1999 | US5871723 CXC chemokines as regulators of angiogenesis |
| 02/16/1999 | US5871714 Compositions for controlling bacterial colonization |
| 02/16/1999 | US5871711 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 02/16/1999 | CA2138020C Pharmaceutical composition containing botulinum b complex |
| 02/16/1999 | CA2122112C Adrenomedullin |
| 02/16/1999 | CA2021576C Agent for preventing and treating opacity of lens |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/16/1999 | CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/13/1999 | CA2240607A1 Novel vascular smooth muscle cell growth factor |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/12/1999 | CA2231728A1 Mray |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006569A1 Cytotoxic polypeptide (fragment) derived from ribonuclease |
| 02/11/1999 | WO1999006565A2 Antifreeze proteins, dna and expression systems |
| 02/11/1999 | WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | WO1999006562A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | WO1999006561A2 Chemokine receptor ccr8 dna and uses thereof |
| 02/11/1999 | WO1999006560A1 Annexin binding protein |
| 02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006556A1 Growth differentiation factor-16 |
| 02/11/1999 | WO1999006555A1 Novel human mmp-20 protein and use of the same |
| 02/11/1999 | WO1999006554A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES |
| 02/11/1999 | WO1999006551A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 02/11/1999 | WO1999006549A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 02/11/1999 | WO1999006547A2 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase |
| 02/11/1999 | WO1999006546A1 Human orthologue of ngd5 protein regulated by opiod treatment |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006536A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs |
| 02/11/1999 | WO1999006445A1 Growth differentiation factor-15 |
| 02/11/1999 | WO1999006444A1 GROWTH DIFFERENTIATION FACTOR, Lefty-1 |
| 02/11/1999 | WO1999006443A1 Growth differentiation factor, lefty-2 |
| 02/11/1999 | WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |